| Registered Number:06261518 |
For the period ended 30 April 2025
England and Wales
Unaudited Financial Statements
For the period ended 30 April 2025
Drugmart Limited
Contents Page
1
Statement of Financial Position
2 to 5
Notes to the Financial Statements
Drugmart Limited
Statement of Financial Position
2024
2025
425,000
425,000
2
| Property, plant and equipment |
136,298
135,749
3
561,298
560,749
108,497
51,976
4
| Trade and other receivables |
253,973
472,096
5
92,393
| Cash and cash equivalents |
73,272
597,344
454,863
| Trade and other payables: amounts falling due within one |
| year |
(452,977)
(356,010)
6
1,886
241,334
Net current assets
| Total assets less current liabilities |
802,632
562,635
| Trade and other payables: amounts falling due after more |
| than one year |
(558,087)
(798,331)
7
(3,159)
(2,998)
| Provisions for liabilities |
1,142
Net assets
1,550
100
100
1,042
1,450
1,142
1,550
Shareholders' funds
| For the period ended 30 April 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006 |
| The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 5
For the period ended 30 April 2025
Drugmart Limited
Statement of Financial Position Continued
| Muhammad Irfan Motala Director |
| These financial statements were approved and authorised for issue by the Board on 24 July 2025 and were signed by: |
| The notes form part of these financial statements |
2 of 5
For the period ended 30 April 2025
Drugmart Limited
Notes to the Financial Statements
Statutory Information
| Drugmart Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number |
| 06261518. |
78 Spotland Road
Rochdale
Lancashire
OL12 6PQ
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
| Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the |
| Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
| modified by the revaluation of certain assets. |
Revenue recognition
| Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. |
Property, plant and equipment
| Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Computer equipment
Motor vehicles
Fixtures and fittings
| No depreciation is provided on the company''s freehold properties since in the opinion of the directors the expected |
| useful lives are sufficiently long and the estimated residual values are sufficiently high that any such depreciation |
| would be immaterial. The directors undertake an annual impairment review of these properties. |
Inventories
| Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. |
Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
3 of 5
For the period ended 30 April 2025
Drugmart Limited
Notes to the Financial Statements Continued
| 2. Intangible fixed assets |
Goodwill
425,000
425,000
425,000
425,000
| 3. Property, plant and equipment |
Motor vehicles
211,793
8,658
83,556
2,450
117,129
3,467
3,467
-
-
-
2,450
83,556
12,125
215,260
117,129
| Provision for depreciation and impairment |
76,044
6,231
67,773
2,040
-
Charge for period
2,918
1,365
1,314
239
-
78,962
7,596
69,087
2,279
-
117,129
171
14,469
4,529
136,298
117,129
410
15,783
2,427
135,749
2024
2025
51,976
108,497
| 5. Trade and other receivables |
2024
2025
189
-
471,907
253,973
253,973
472,096
4 of 5
For the period ended 30 April 2025
Drugmart Limited
Notes to the Financial Statements Continued
| 6. Trade and other payables: amounts falling due within one year |
2024
2025
| Bank loans and overdraft (secured) |
8,588
45,000
309,567
297,029
| Taxation and social security |
8,208
13,926
29,647
97,022
356,010
452,977
| 7. Trade and other payables: amounts falling due after more than one year |
2024
2025
| Bank loans and overdraft (secured) |
633,393
350,445
164,938
207,642
798,331
558,087
| 8. Average number of persons employed |
During the year the average number of employees was 19 (2024 : 20)
5 of 5